An ‘electric nose’ capable of sniffing out hard-to-detect cancers with 95 percent accuracy may soon change the way specialists diagnose the potentially fatal disease.
Scientists at the University of Pennsylvania designed an artificial intelligent-powered system equipped with nanosensors to identify vapors from blood samples that are specific to benign, pancreatic and ovarian cancer cells.
The tool also correctly identified all patients with early-stage cancers and did so in less than 20 minutes – traditional methods can take days or weeks to produce results.
Read more of the original article from DailyMail
